Botanical species · safety record

Angelica pubescens

The EFSA Compendium of Botanicals holds 6 constituent measurements for Angelica pubescens. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Angelica pubescens Maxim.

6Constituent measurements

0Safety records

5Cited sources

276Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 276 licensed products naming Angelica pubescens as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA

Source material stated

Angelica pubescens root
Dried root(s)
New material
Root
Root extract
Whole plant

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Coumarins	Roots and other underground parts	Solvent extraction	—	Chromatographic tests	No resolvable identifier
Coumarins	Roots and other underground parts	Solvent extraction	—	UHPLC-MS-MS	No resolvable identifier
Coumarins	Roots and other underground parts	Solvent extraction	—	Chromatographic tests	No resolvable identifier
Coumarins	—	Solvent extraction	—	—	No resolvable identifier
Coumarins	—	—	—	—	No resolvable identifier
Furanocoumarins	Roots and other underground parts	Solvent extraction	—	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Hata, K., Kozawa, M. Constitution of angelol, a new coumarin isolated from the root of Angelica pubescens. Tetrahedron letters, 1965, vol. (50), p. 4557-62.
Yang, Yan-Fang., Zhang, Lei., Zhang, You-Bo., Yang, Xiu-Wei. Simultaneous assessment of absorption characteristics of coumarins from Angelicae Pubescentis Radix: In vitro transport across Caco-2 cell and in vivo pharmacokinetics in rats after oral administration. Journal of chromatography b: analytical technologies in the biomedical and life sciences, 2017, vol. 1060, p. 308-315.
Liu, Jianghua., Xu, Suixu., Meng, Zhiyun., Yao, Xinsheng., Wu, Yuqiang. Further isolation of coumarin from Angelica pubescens Maxim f. Shan et Yuan. Journal of chinese pharmaceutical sciences, 1997, vol. 6, no. 4, p. 221-224.
Ding, Xifei., Feng, Xu., Dong, Yunfa., Zhao, Xingzeng., Chen, Yu., Liang, Yongqi. Study on coumarins of Angelica pubescens. Zhongchengyao, 2009, vol. 31, no. 7, p. 1102-1104.
Liu, Jianghua., Tan, Yan., Chen, Yuping., Xu, Suixu., Yao, Xinsheng. Chemical constituents of Angelica pubescens. Zhongcaoyao, 1994, vol. 25, no. 6, p. 288-91.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature